Drugs@FDA document

PAVBLU Letter · BLA 761298 SUPPL-5

Drugs@FDA document · AMGEN INC · Apr 30, 2026

Key facts

Drug name PAVBLU
Document type Letter
Application BLA761298
Submission SUPPL-5
Company AMGEN INC
Document date Apr 30, 2026
FDA document accessdata.fda.gov

At a glance

  • 1–9 Documents for this application

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA documents

Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date:

Browse all Drugs@FDA documents